On July 10 of 1914, my great-grandfather Ichitaro Iwaki founded Iwaki-Ichitaro Shoten, an imported drug wholesale store in Nihonbashi Honcho, a heartland of the pharmaceutical business in Tokyo. He received his customers and patients laying utmost importance always on the true sincerity and honesty and established the basis of our Company having its head office at the same place over 100 years since then.
My grandfather Kentaro Iwaki succeeded his family business from his father as the second president, strived for business growth not only in Japan but also in the global market, and successfully made the company to evolve from a medical wholesale to a pharmaceutical trading company.
Furthermore, he diversified the lines of business by adding cosmetics, health foods and industrial chemical products and, also, started manufacturing business which made the company systemized to contribute to by far more number of customers.
My father Osamu Iwaki, the third president, was commissioned to steer the Company to live through difficult time after high economic growth of Japan ended. After reconsidering strategies that continued for several decades to focus on expansion and diversification of business, he succeeded in establishment of a stable management framework by strengthening its operational platform without making major changes of business domain as a specialized trading company dealing in healthcare and fine chemical products. In result, the company was listed in the first section of Tokyo Stock Exchange Market in 2005 as a proof of credibility, and, in the year 2014, the company celebrated its 100th anniversary.
Since our company was established, we have grown from a medical wholesaler to a pharmaceutical trading company. We presently operate as a specialized trading company possessing a wide ranging value chain encompassing everything from raw material manufacturing to retail sales. We owe this growth to the support of our many stakeholders, including our customers and trading partners. In January 2016 our company group announced the Vision “i-111” medium- to long-term plan. This established a medium- to long-term management plan to be realized by 2025, the 111th anniversary of our company’s founding. 2019 marks the fourth year of this medium- to long-term management plan. In the previous three years our company group has seen excellent business results, with the previous two consecutive fiscal periods achieving record profits. I believe these results are indicative of our realizing the company motto of “honesty, social contribution and trust,” if only to a small degree.
Using the network and know-how our company has cultivated over the last 100 years as a resource, we will strive to become a group enterprise that is even more honest, contributes more to society, and garners even greater trust.
We look forward to your continuous and steadfast supports.
February 22, 2019
President & CEO